This bulletin was incorrectly attributed in the October 9th edition of the Lexology newsletter. We apologize for this error.
The Supreme Court of Canada refused leave in Teva Canada Limited v. Sanofi-Aventis Canada Inc. and Sanofi-Aventis Deutschland GmbH (Case No.34325). The decisions of the Prothonotary, the Court and the Court of Appeal related to portions of Teva's counterclaim relating to loss of permanent market share, loss of increased sales and lost market share. We summarized the Court's decision, and the Court of Appeal's decision.